GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocular Therapeutix Inc (STU:0OT) » Definitions » Cyclically Adjusted PB Ratio

Ocular Therapeutix (STU:0OT) Cyclically Adjusted PB Ratio : 4.97 (As of Sep. 20, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Ocular Therapeutix Cyclically Adjusted PB Ratio?

As of today (2024-09-20), Ocular Therapeutix's current share price is €8.052. Ocular Therapeutix's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 was €1.62. Ocular Therapeutix's Cyclically Adjusted PB Ratio for today is 4.97.

The historical rank and industry rank for Ocular Therapeutix's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:0OT' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.77   Med: 5.14   Max: 9.91
Current: 5.13

During the past years, Ocular Therapeutix's highest Cyclically Adjusted PB Ratio was 9.91. The lowest was 2.77. And the median was 5.14.

STU:0OT's Cyclically Adjusted PB Ratio is ranked worse than
79.93% of 603 companies
in the Biotechnology industry
Industry Median: 1.63 vs STU:0OT: 5.13

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Ocular Therapeutix's adjusted book value per share data for the three months ended in Jun. 2024 was €2.255. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.62 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ocular Therapeutix Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Ocular Therapeutix's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocular Therapeutix Cyclically Adjusted PB Ratio Chart

Ocular Therapeutix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 3.71 3.20

Ocular Therapeutix Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.94 4.28 3.20 6.20 3.87

Competitive Comparison of Ocular Therapeutix's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Ocular Therapeutix's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocular Therapeutix's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocular Therapeutix's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ocular Therapeutix's Cyclically Adjusted PB Ratio falls into.



Ocular Therapeutix Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Ocular Therapeutix's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=8.052/1.62
=4.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocular Therapeutix's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Ocular Therapeutix's adjusted Book Value per Share data for the three months ended in Jun. 2024 was:

Adj_Book=Book Value per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=2.255/132.5538*132.5538
=2.255

Current CPI (Jun. 2024) = 132.5538.

Ocular Therapeutix Quarterly Data

Book Value per Share CPI Adj_Book
201409 2.387 100.428 3.151
201412 2.231 99.070 2.985
201503 2.245 99.621 2.987
201506 3.933 100.684 5.178
201509 3.560 100.392 4.701
201512 3.323 99.792 4.414
201603 2.908 100.470 3.837
201606 2.526 101.688 3.293
201609 2.231 101.861 2.903
201612 1.970 101.863 2.564
201703 2.065 102.862 2.661
201706 1.471 103.349 1.887
201709 1.026 104.136 1.306
201712 0.745 104.011 0.949
201803 1.070 105.290 1.347
201806 1.017 106.317 1.268
201809 0.963 106.507 1.199
201812 0.760 105.998 0.950
201903 0.530 107.251 0.655
201906 0.166 108.070 0.204
201909 0.213 108.329 0.261
201912 -0.065 108.420 -0.079
202003 -0.182 108.902 -0.222
202006 0.075 108.767 0.091
202009 -0.056 109.815 -0.068
202012 0.823 109.897 0.993
202103 0.919 111.754 1.090
202106 0.871 114.631 1.007
202109 0.969 115.734 1.110
202112 1.015 117.630 1.144
202203 0.944 121.301 1.032
202206 0.809 125.017 0.858
202209 0.606 125.227 0.641
202212 0.433 125.222 0.458
202303 0.117 127.348 0.122
202306 0.036 128.729 0.037
202309 0.093 129.860 0.095
202312 0.727 129.419 0.745
202403 2.426 131.776 2.440
202406 2.255 132.554 2.255

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ocular Therapeutix  (STU:0OT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Ocular Therapeutix Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Ocular Therapeutix's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ocular Therapeutix Business Description

Traded in Other Exchanges
Address
24 Crosby Drive, Bedford, MA, USA, 01730
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Ocular Therapeutix Headlines

No Headlines